Investment Summary

CannaPharmaRX Invests In GN Ventures

On February 28, 2019, CannaPharmaRX invested in consumer products company GN Ventures

Investment Highlights
  • This is CannaPharmaRX’s 1st transaction in the Consumer Products sector.
  • This is CannaPharmaRX’s 2nd transaction in Canada.
  • This is CannaPharmaRX’s 1st transaction in Alberta.

Investment Summary

Date 2019-02-28
Target GN Ventures
Sector Consumer Products
Investor(s) CannaPharmaRX
Deal Type Stake Purchase

Target

GN Ventures

Alberta, Canada
GN Ventures Ltd. is an Alberta corporation, engaged in the development of Canadian cannabis cultivation facilities.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

CannaPharmaRX

Calgary, Alberta, Canada

Category Company
Founded 1998
Sector Life Science
Employees4
DESCRIPTION

CannaPharmaRX is an early-stage pharmaceutical company whose purpose was to advance cannabinoid research and discovery using proprietary formulation and drug delivery technology then under development. CannaPharmaRX was founded in 1998 and is based in Calgary, Alberta.


DEAL STATS #
Overall 2 of 2
Sector: Consumer Products M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
State: Alberta M&A 1 of 1
Country: Canada M&A 2 of 2
Year: 2019 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-01-08 Alternative Medical Solutions

Ontario, Canada

Alternative Medical Solutions, Inc. is a late-stage marijuana licensed producer applicant in Canada currently operating in the Pre-License Inspection and Licensing phase, which is Stage 5 of 6, with a fully approved license.

Buy -